“…1-a). Various analytical techniques have been reported for determination of AML, either alone or in combination with other drugs, including, spectrophotometric techniques (Attimarad et al 2019;Erden et al 2016;Hegazy et al 2015;Karadurmuş et al 2018;Khachornsakkul and Dungchai 2020;Mahant et al 2016;Saad et al 2016;Siridevi et al 2019), spectrofluorimetric techniques (Attala et al 2020;Dinç et al 2017;El-Kosasy et al 2015;Ibrahim et al 2015;Mabrouk et al 2018;Mohamed et al 2016;Mohammed 2015;Nasr and Shalan 2020;Sh Shalan et al 2015;Shereen Shalan and Nasr 2019), electrochemical techniques (Erden et al 2016;Wei et al 2016) and chromatographic techniques such as TLC-densitometry (Patel et al 2020a, b), LC-MS/ MS (Rezk and Badr 2020) and HPLC (Alaama et al 2015;Attimarad et al 2020;Desai et al 2019;Duraisamy and Jaganathan 2017;Ebeid et al 2015;Karadurmuş et al 2018;Mahant et al 2016;Nagamani et al 2020;Naik et al 2020;Patel et al Patel et al 2020a, b;Saleh et al 2020;Saputri et al 2018). Perindopril (PER), is an antihypertensive nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor used to treat hypertension and stable coronary artery disease with nomenclature of (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid (Fig.…”